Publications by authors named "Ellen Snyder"

Claim this Profile
R
Review of Recent Pharmacoepidemiologic Post-Market Safety Studies Through the Lens of the Estimand Framework.
Yong Ma, Jonathan Haddad, Wei Liu, Ellen Snyder, Dimitri Bennett

Ther Innov Regul Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Review of Recent Pharmacoepidemiologic Post-Market Safety Studies Through the Lens of the Estimand Framework.
Yong Ma, Jonathan Haddad, Wei Liu, Ellen Snyder, Dimitri Bennett

Ther Innov Regul Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunities for tuberculosis elimination in the Canadian Arctic: cost-effectiveness of community-wide screening in a remote Arctic community.
Alice Zwerling, Edwina Veerasingam, Ellen Snyder, Andrea Schertzer, Keith Travers

Lancet Reg Health Am· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testing the diagnostic accuracy of common questions for seizure diagnosis: Challenges and future directions.
Ellen Snyder, Stefan Sillau, Kelly G Knupp, Jacqueline French, Amber Khanna

Epilepsy Behav· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety profile of pembrolizumab monotherapy based on an aggregate safety evaluation of 8937 patients.
Julie R Brahmer, Georgina V Long, Omid Hamid, Edward B Garon, Roy S Herbst, Ellen Snyder

Eur J Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploratory analyses of clinical trial data used for health technology assessments: a retrospective evaluation.
Björn J Oddens, Israel T Agaku, Ellen S Snyder, William Malbecq, William Wb Wang

BMJ Open· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse Outcomes Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant B.1.351 Infection in Vaccinated Residents of a Long-Term Care Home, Ontario, Canada.
Ahmed Vanker, Allison J McGeer, Gray O'Byrne, Ellen C R Snyder, David A Salisbury

Clin Infect Dis· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The language of seizure identification: A qualitative investigation.
Jacob Pellinen, Ellen Snyder, Kelly G Knupp

Epilepsy Behav· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot evaluation of a consumer wearable device to assess sleep in a clinical polysomnography trial of suvorexant for treating insomnia in patients with Alzheimer's disease.
Vladimir Svetnik, Ting-Chuan Wang, Paulette Ceesay, Ellen Snyder, Omar Ceren

J Sleep Res· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of the single-item Patient Global Impression-Severity scale as a self-reported assessment of insomnia severity.
Ellen S Snyder, Peining Tao, Vladimir Svetnik, Christopher Lines, W Joseph Herring

J Sleep Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effectiveness of substance use interventions for homeless and vulnerably housed persons:  A systematic review of systematic reviews on supervised consumption facilities, managed alcohol programs, and pharmacological agents for opioid use disorder.
Olivia Magwood, Ginetta Salvalaggio, Michaela Beder, Claire Kendall, Victoire Kpade, Ellen Snyder

PLoS One· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How well can a large number of polysomnography sleep measures predict subjective sleep quality in insomnia patients?
Vladimir Svetnik, Ellen S Snyder, Peining Tao, Thomas Roth, Christopher Lines

Sleep Med· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trial.
W Joseph Herring, Paulette Ceesay, Ellen Snyder, Donald Bliwise, Kerry Budd

Alzheimers Dement· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of pembrolizumab in patients with advanced tumors.
Marianne J H van Vugt, Julie A Stone, Rik H J M M De Greef, Ellen S Snyder, Leslie Lipka

J Immunother Cancer· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statistical planning in confirmatory clinical trials with multiple treatment groups, multiple visits, and multiple endpoints.
Hengrui Sun, Ellen Snyder, Gary G Koch

J Biopharm Stat· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of suvorexant on the Insomnia Severity Index in patients with insomnia: analysis of pooled phase 3 data.
W Joseph Herring, Kathryn M Connor, Ellen Snyder, Duane B Snavely, Charles M Morin

Sleep Med· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A New Single-Item Sleep Quality Scale: Results of Psychometric Evaluation in Patients With Chronic Primary Insomnia and Depression.
Ellen Snyder, Bing Cai, Carla DeMuro, Mary F Morrison, William Ball

J Clin Sleep Med· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insight Into Reduction of Wakefulness by Suvorexant in Patients With Insomnia: Analysis of Wake Bouts.
Vladimir Svetnik, Ellen S Snyder, Peining Tao, Thomas E Scammell, Thomas Roth

Sleep· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suvorexant in Elderly Patients with Insomnia: Pooled Analyses of Data from Phase III Randomized Controlled Clinical Trials.
W Joseph Herring, Kathryn M Connor, Ellen Snyder, Duane B Snavely, Ying Zhang

Am J Geriatr Psychiatry· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical profile of suvorexant for the treatment of insomnia over 3 months in women and men: subgroup analysis of pooled phase-3 data.
W Joseph Herring, Kathryn M Connor, Ellen Snyder, Duane B Snavely, Ying Zhang

Psychopharmacology (Berl)· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EEG spectral analysis of NREM sleep in a large sample of patients with insomnia and good sleepers: effects of age, sex and part of the night.
Vladimir Svetnik, Ellen S Snyder, Junshui Ma, Peining Tao, Christopher Lines

J Sleep Res· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Programmed Death-1 Blockade With Pembrolizumab in Patients With Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure.
Philippe Armand, Margaret A Shipp, Vincent Ribrag, Jean-Marie Michot, Pier Luigi Zinzani, Ellen S Snyder

J Clin Oncol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical Trials.
W Joseph Herring, Kathleen M Connor, Ellen Snyder, Duane B Snavely, Ying Zhang

J Clin Sleep Med· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Dose-Ranging Study Evaluating the Efficacy and Safety of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Primary Insomnia.
Kathryn M Connor, Erin Mahoney, Saheeda Jackson, Jill Hutzelmann, Xin Zhao, Ellen Snyder

Int J Neuropsychopharmacol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of suvorexant on sleep architecture and power spectral profile in patients with insomnia: analysis of pooled phase 3 data.
Ellen Snyder, Junshui Ma, Vladimir Svetnik, Kathryn M Connor, Christopher Lines

Sleep Med· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis